Physician profile
Felicia Merriweather Knowles
NPI 1952354367
$40,406.43
in general payments reported to CMS, 2019-2025
13 companies · $36K in 2025
The $36K reported for 2025 was more than what 99% of Developmental - Behavioral Pediatrics providers received nationally (typical 2025 total: $79.84).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $434 · 2021: $917 · 2022: $1,077 · 2023: $611 · 2024: $737 · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $33K · Food and Beverage: $2,712 · Travel and Lodging: $2,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $32,576.00 |
| Food and Beverage | $2,712.31 |
| Travel and Lodging | $2,098.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $36,189.27 | 2021-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $1,485.41 | 2019-2025 | Dyanavel Xr, Quillivant, Quillichew Er |
| Ironshore Pharmaceuticals INC. | $1,023.89 | 2019-2024 | Jornay Pm |
| Corium, LLC | $603.60 | 2022-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $249.41 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $226.63 | 2019-2022 | |
| Neos Therapeutics, Lp | $215.64 | 2019-2020 | |
| Adlon Therapeutics L.P. | $158.86 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $72.50 | 2020 | |
| Acadia Pharmaceuticals INC | $58.35 | 2025 | Daybue |
| Shire North American Group INC | $55.83 | 2019 | |
| Noven Therapeutics, LLC | $37.73 | 2024 | Xelstrym |
| Arbor Pharmaceuticals, INC. | $29.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felicia Knowles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.